Income Statement - Enliven Therapeutics, Inc. (ELVN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost of revenue | 0.26 | 0.32 | 0.30 | 0.62 | 0.10 | 0.10 | 0.03 | ||
| Gross profit | -0.26 | -0.32 | -0.30 | -0.62 | -0.10 | -0.10 | -0.03 | ||
| Total operating expenses | 119.40 | 104.55 | 83.53 | 38.79 | 24.76 | 9.32 | 24.08 | 10.68 | 8.91 |
| Operating income | -119.66 | -104.55 | -83.53 | -38.79 | -24.76 | -9.32 | -24.12 | -10.68 | -8.91 |
| Non-operating income (net) | 15.96 | 15.76 | 11.95 | 1.13 | 0.02 | -9.65 | 0.65 | -0.66 | 9.13 |
| Income before tax | -103.69 | -88.79 | -71.58 | -37.66 | -24.74 | -18.97 | -23.46 | -11.34 | 0.22 |
| Income tax expense | 0.23 | 1.30 | 0.09 | -0.02 | -0.03 | 0.65 | -0.82 | 0.22 | |
| Net income | -103.69 | -89.02 | -71.58 | -37.66 | -24.74 | -18.97 | -23.46 | -11.34 |
Show Quarterly Income Statement
Income Statement - Enliven Therapeutics, Inc. (ELVN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 | 0.00 | 0.00 | 0.00 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Cost of revenue | 0.01 | 0.05 | 0.08 | 0.07 | 0.16 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.10 | 0.50 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | ||||||||||
| Gross profit | -0.01 | -0.05 | -0.08 | -0.07 | 0.16 | -0.08 | -0.08 | -0.08 | 0.36 | -0.08 | -0.07 | -0.07 | -0.10 | -0.50 | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | ||||||||||
| Total operating expenses | 27.82 | 34.24 | 25.10 | 28.58 | 31.69 | 26.90 | 27.07 | 24.60 | 25.99 | 22.73 | 24.25 | 20.13 | 16.42 | 10.16 | 10.93 | 9.02 | 8.68 | 8.40 | 13.64 | 13.14 | 10.26 | 11.55 | 12.49 | 10.30 | 7.35 | 7.48 | 6.88 | 5.56 | 4.19 |
| Operating income | -27.82 | -34.29 | -25.10 | -28.58 | -31.69 | -26.90 | -27.07 | -24.60 | -25.99 | -22.73 | -24.25 | -20.13 | -16.42 | -10.16 | -10.93 | -9.02 | -8.68 | -8.40 | -13.66 | -13.17 | -10.28 | -11.55 | -12.49 | -10.30 | -7.35 | -7.48 | -6.88 | -5.56 | -4.19 |
| Non-operating income (net) | 4.20 | 4.62 | 4.95 | 3.25 | 3.15 | 3.72 | 3.91 | 4.89 | 3.25 | 3.36 | 3.48 | 3.41 | 1.69 | 0.61 | 0.38 | 0.13 | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.07 | 0.10 | 0.14 | 0.23 | 0.26 | 0.16 | 0.00 |
| Income before tax | -23.63 | -29.67 | -20.15 | -25.34 | -28.54 | -23.18 | -23.16 | -19.72 | -22.74 | -19.37 | -20.77 | -16.72 | -14.72 | -9.55 | -10.55 | -8.89 | -8.67 | -8.39 | -13.65 | -13.16 | -10.26 | -11.52 | -12.42 | -10.20 | -7.22 | -7.25 | -6.62 | -5.40 | -4.19 |
| Income tax expense | -0.50 | 0.23 | 0.04 | 5.19 | -3.49 | -0.05 | -1.69 | 0.09 | 0.24 | -0.44 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.07 | 0.10 | 0.14 | 0.23 | 0.26 | 0.12 | -0.04 | ||||||
| Net income | -23.63 | -29.67 | -20.15 | -25.34 | -28.54 | -23.18 | -23.16 | -19.95 | -22.74 | -19.37 | -20.77 | -16.72 | -14.72 | -9.55 | -10.55 | -8.89 | -8.67 | -8.39 | -13.65 | -13.16 | -10.26 | -11.52 | -12.42 | -10.20 | -7.22 | -7.25 | -6.62 | -5.40 | -4.19 |